These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15498383

  • 21. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens.
    Kuzushita N, Gregory SH, Monti NA, Carlson R, Gehring S, Wands JR.
    Gastroenterology; 2006 Feb; 130(2):453-64. PubMed ID: 16472599
    [Abstract] [Full Text] [Related]

  • 22. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.
    Chen L, Tang XD, Yu ST, Ai ZH, Fang DC, Cai YG, Luo YH, Liang GP, Yang SM.
    J Pathol; 2009 Apr; 217(5):685-92. PubMed ID: 19142972
    [Abstract] [Full Text] [Related]

  • 23. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
    Cho HI, Kim EK, Park SY, Lee SK, Hong YK, Kim TG.
    Cancer Lett; 2007 Dec 18; 258(2):189-98. PubMed ID: 17931768
    [Abstract] [Full Text] [Related]

  • 24. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S.
    J Clin Oncol; 2005 Dec 10; 23(35):8942-9. PubMed ID: 16204009
    [Abstract] [Full Text] [Related]

  • 25. [Immunization with dendritic cells infected with mTERT adenovirus vector effectively elicits immunity against mouse H22 hepatoma in vivo].
    Jiang N, Wang GS, Li H, Zhang J, Zhang JF, Yi SH, Yi HM, Yang Y, Cai CJ, Lu MQ, Chen GH.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 10; 31(6):405-9. PubMed ID: 19950546
    [Abstract] [Full Text] [Related]

  • 26. [Immunotherapy against tumor with dendritic cell sensitized by necrotic tumor tissue after microwave coagulation therapy].
    Yao LC, Yang RJ.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2552-6. PubMed ID: 18067832
    [Abstract] [Full Text] [Related]

  • 27. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
    Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS, Vieweg J, Gilboa E.
    Nat Med; 2000 Sep 25; 6(9):1011-7. PubMed ID: 10973321
    [Abstract] [Full Text] [Related]

  • 28. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
    Subklewe M, Sebelin K, Block A, Meier A, Roukens A, Paludan C, Fonteneau JF, Steinman RM, Münz C.
    Hum Immunol; 2005 Sep 25; 66(9):938-49. PubMed ID: 16360833
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
    Okada N, Iiyama S, Okada Y, Mizuguchi H, Hayakawa T, Nakagawa S, Mayumi T, Fujita T, Yamamoto A.
    Cancer Gene Ther; 2005 Jan 25; 12(1):72-83. PubMed ID: 15389286
    [Abstract] [Full Text] [Related]

  • 32. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
    Xie J, Xiong L, Tao X, Li X, Su Y, Hou X, Shi H.
    Lung Cancer; 2010 Jun 25; 68(3):338-45. PubMed ID: 19671483
    [Abstract] [Full Text] [Related]

  • 33. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H, Brewin J, Kinnon C, Veys P, Amrolia PJ.
    J Immunother; 2007 Jun 25; 30(5):544-56. PubMed ID: 17589295
    [Abstract] [Full Text] [Related]

  • 34. Potent dendritic cell vaccine loaded with latent membrane protein 2A (LMP2A).
    Chen Y, Yao K, Wang B, Qing J, Liu G.
    Cell Mol Immunol; 2008 Oct 25; 5(5):365-72. PubMed ID: 18954560
    [Abstract] [Full Text] [Related]

  • 35. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H.
    Gene Ther; 2004 Nov 25; 11(21):1551-8. PubMed ID: 15343358
    [Abstract] [Full Text] [Related]

  • 36. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP, Sauter BV, Huang TG, Meseck M, Woo SL, Chen SH.
    Gene Ther; 2005 Oct 25; 12(20):1526-33. PubMed ID: 15973445
    [Abstract] [Full Text] [Related]

  • 37. Interferon-gamma expressing EBV LMP2A-specific T cells for cellular immunotherapy.
    Sun Q, Brewer N, Dunham K, Chen L, Bao L, Burton R, Lucas KG.
    Cell Immunol; 2007 Apr 25; 246(2):81-91. PubMed ID: 17663985
    [Abstract] [Full Text] [Related]

  • 38. RNA-containing adenovirus/polyethylenimine transfer complexes effectively transduce dendritic cells and induce antigen-specific T cell responses.
    Gust TC, Diebold SS, Cotten M, Zenke M.
    J Gene Med; 2004 Apr 25; 6(4):464-70. PubMed ID: 15079821
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J, Lil GW, Sui YF, Sun YJ, Huang YY, Si SY, Ge W, Song HP.
    Hepatogastroenterology; 2007 Apr 25; 54(75):681-7. PubMed ID: 17591041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.